Breast Imaging

Women's health related to breast imaging, including mammography, breast MRI, ABUS, automated breast ultrasound, breast ultrasound, breast biopsy, PEM and positron emission mammography.

Attending the two most recent screening appointments before a breast cancer diagnosis protects against breast cancer death, according to a Queen Mary University of London study of over half a million Swedish women conducted over 24 years
News | Breast Imaging
Attending Consecutive Mammography Screens Protects Against Breast Cancer Death

March 12, 2021 — For women who had participated in both of their previous two screening examinations, the incidence of ...

Time March 12, 2021
arrow
Breast cancer is the most common fatal cancer in women. Early detection increases a woman's chances of recovery. Magnetic Resonance Imaging (MRI) is an accurate technique for detecting and classifying tumors in breast tissue.
News | MRI Breast
Simple MRI Measurement Could Avoid 30% of Breast Biopsies

March 9, 2021 — Breast cancer is the most common fatal cancer in women. Early detection increases a woman's chances of ...

Time March 09, 2021
arrow
A comparison of standard mammography imaging (left) in a woman with dense breasts and a breast MRI imaging study (right) showing a clearly defined cancer and is extremely hard to detect on the mammograms.
Feature | MRI Breast | By Dave Fornell, Editor
Use of Breast MRI Screening in Women With Dense Breasts

Dense breast tissue can hide cancers in mammograms in about half of women. Supplemental imaging is often needed to ...

Time March 04, 2021
arrow
Researchers said women who skip even one scheduled mammography screening before a breast cancer diagnosis face a significantly higher risk of dying from the cancer.
News | Mammography
Skipping Mammogram Increases Risk of Death from Breast Cancer

March 3, 2021 — Attendance at regular mammography screening substantially reduces the risk of dying from breast cancer ...

Time March 03, 2021
arrow
55-year-old woman who underwent screening mammogram and ultrasound 7 days after first COVID-19 vaccination dose. Screening mammogram and US demonstrated unilateral left axillary lymph node with cortical thickness of 5 mm on ultrasound (not shown). BI-RADS category 0 was assigned. Ultrasound from diagnostic work-up performed 7 days later showed no change in lymph node size. BI-RADS 3 was assigned. #COVIDvaccine #COVID19
News | Breast Imaging
COVID-19 Vaccination Axillary Adenopathy Detected During Breast Imaging

February 24, 2021 — An open-access article in ARRS’ American Journal of Roentgenology (AJR) describes the clinical and ...

Time February 24, 2021
arrow
Breast Cancer Index added to National Comprehensive Cancer Network guidelines to predict benefit from extended endocrine therapy
News | Women's Health
Hologic Completes Acquisition of Biotheranostics, Enabling Entry into Growing Oncology Market

February 23, 2021 — Hologic, Inc. has completed its previously announced acquisition of molecular oncology leader ...

Time February 23, 2021
arrow
Examples of the imaging performance of XPCI-CT (b,e) compared to conventional specimen radiography (a,d) and benchmarked against histopathology (c,f). he top row focuses on the similarity between the XPCI-CT slice in (b) and the histological slice in (c). Arrow 1 indicates margin involvement, arrow 2 a variation in density in the internal structure of the tumour mass, arrow 3 tumour-induced inflammation. All this is confirmed by the histological slice in (c), and hardly visible in the conventional image in
News | Breast Imaging
Advances in X-ray Imaging can Help Patients with Breast Cancer

February 22, 2021 — A new X-ray imaging scanner to help surgeons performing breast tumor removal surgery has been ...

Time February 22, 2021
arrow
F-18 FES PET images of patients with ER+/PR+/HER2- invasive ductal carcinoma. Left panel: Progressive disease seen at the 8-week time-point in a patient on sequential therapy. Right panel: Stable disease through all 3 time-points, remaining on study therapy for 6.7 months until disease progression on combined vorinostat aromatase inhibitor therapy. Image created by Lanell M Peterson, Research Scientist, University of Washington Medical Oncology, Seattle WA.
News | Molecular Imaging
Molecular Imaging Determines Effectiveness of Novel Metastatic Breast Cancer Treatment

February 22, 2021 — Molecular imaging can successfully predict response to a novel treatment for ER-positive, HER2 ...

Time February 22, 2021
arrow
Screening strategy based on baseline breast density at age 40 may be effective and cost-effective for reducing breast cancer mortality
News | Breast Density
Risk-based Breast Cancer Screening

February 10, 2021 — A mammography screening strategy based on a baseline breast density measure at age 40 may be the ...

Time February 10, 2021
arrow
Comparison of breast cancer mortality rates (red squares) and distant-stage breast cancer incidence rates from SEER9 (blue dots) and SEER18 (green dots) per 100,000 for white women aged, A, 20–39, B, 40–69, and, C, 70–79 years (3,7,8).
News | Breast Imaging
Breast Cancer Death Rates Stop Declining in Younger Women

February 10, 2021 — Breast cancer death rates have stopped declining for women in the U.S. younger than age 40, ending a ...

Time February 10, 2021
arrow
After acquiring the molecular breast imaging (MBI) assets from GE Healthcare and Dilon Technologies, Inc., SmartBreast Corporation (SmartBreast), a privately held company focused on breast cancer screening and diagnosis, announced today that it has formed a partnership with FoxSemicon Integrated Technologies, Inc. (FITI) to manufacture molecular breast imaging (MBI) systems.
News | Breast Imaging
SmartBreast Forms Molecular Breast Imaging Partnership with FITI

February 9, 2021 — After acquiring the molecular breast imaging (MBI) assets from GE Healthcare and Dilon Technologies ...

Time February 09, 2021
arrow
News | Breast Imaging
Female Breast Cancer Surpasses Lung as the Most Commonly Diagnosed Cancer Worldwide

February 8, 2021 — Cancer ranks as a leading cause of death in every country in the world, and, for the first time ...

Time February 08, 2021
arrow
Volpara Health, a health technology software company whose integrated breast care platform assists in the delivery of personalized patient care, announced the acquisition of CRA Health, LLC, a breast cancer risk assessment company spinoff from Massachusetts General Hospital — a Harvard Medical School teaching hospital.
News | Breast Imaging
Volpara Acquires Breast Cancer Risk Assessment Company CRA Health, LLC.

February 2, 2021 — Volpara Health, a health technology software company whose integrated breast care platform assists in ...

Time February 02, 2021
arrow
A nationwide panel of experts has developed the first mammography guidelines for older survivors of breast cancer, providing a framework for discussions between survivors and their physicians on the pros and cons of screening in survivors' later years.
News | Mammography
First Mammography Screening Guidelines Issued for Older Survivors of Breast Cancer

January 29, 2021 — A nationwide panel of experts has developed the first mammography guidelines for older survivors of ...

Time January 29, 2021
arrow
Hologic, Inc. announced the expansion of its ultrasound portfolio with the launch of the new SuperSonic MACH 20 ultrasound system
News | Ultrasound Imaging
Hologic Expands Ultrasound Portfolio to Address Full Spectrum of Imaging Needs

January 29, 2021— Hologic, Inc. announced the expansion of its ultrasound portfolio with the launch of the new ...

Time January 29, 2021
arrow
The four standard views of an individual mammogram were fed into Mirai. The image encoder mapped each view to a vector, and the image aggregator combined the four view vectors into a single vector for the mammogram. In this work, we used a single shared ResNet-18 as an image encoder, and a transformer as our image aggregator. The risk factor predictor module predicted all the risk factors used in the Tyrer-Cuzick model, including age, detailed family history, and hormonal factors, from the mammogram vector.
News | Breast Imaging
Mammogram-based Breast Cancer Risk Model Could Lead to Better Screening Guidelines

January 28, 2021 — A new machine learning algorithm based on mammograms can estimate the risk of breast cancer in women ...

Time January 28, 2021
arrow
Radiologists have recently taken on the role of activists and are tackling pressing issues in healthcare, including breast density
Feature | Women's Health | By Fazila Seker, Ph.D.
Stepping Up to the Big Issues

Radiologists — who have long been professionals in the metaphorical and literal back-rooms of healthcare — have recently ...

Time January 20, 2021
arrow
Solis Mammography, the nation’s largest independent provider of breast health and diagnostic services, announced that it has expanded its state-of-the-art multimodality medical imaging capabilities in Maryland, Virginia and Washington, DC through the acquisition of Progressive Radiology.
News | Breast Imaging
Solis Mammography Announces the Acquisition of Progressive Radiology

January 15, 2021 — Solis Mammography, the nation’s largest independent provider of breast health and diagnostic services ...

Time January 15, 2021
arrow
Novel Coronavirus SARS-CoV-2 Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: National Institute of Allergy and Infectious Diseases, NIH
News | Coronavirus (COVID-19)
Study Shows Sharp Decline in Cancer Screenings During First COVID-19 Surge

January 15, 2021 — In one of the first studies to examine the impact of the COVID-19 pandemic on cancer diagnoses ...

Time January 15, 2021
arrow
A, Contrast-enhanced axial T1-weighted fat-saturated image from baseline MRI before initiation of neoadjuvant therapy shows irregular mass (arrow) in upper inner right breast corresponding to biopsy-proven carcinoma. B, Contrast-enhanced axial T1-weighted fat-saturated image from follow-up MRI performed 3 months after initiation of neoadjuvant therapy shows decrease in size of right breast cancer (arrow). C, Contrast-enhanced axial T1-weighted fat-saturated image 3 months after initiation of neoadjuvant the
News | MRI Breast
New Suspicious Lesions on Breast MRI in Neoadjuvant Therapy

January 15, 2021 — According to ARRS' American Journal of Roentgenology (AJR), new suspicious findings occurred in 5.5% ...

Time January 15, 2021
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now